A detailed history of Centiva Capital, LP transactions in Pfizer Inc stock. As of the latest transaction made, Centiva Capital, LP holds 7,200 shares of PFE stock, worth $184,680. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,200
Previous 20,600 65.05%
Holding current value
$184,680
Previous $576,000 63.89%
% of portfolio
0.0%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$27.7 - $31.39 $1.45 Million - $1.64 Million
-52,263 Reduced 95.21%
2,631 $76,000
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $871,848 - $1.02 Million
34,515 Added 169.37%
54,894 $1.54 Million
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $527,612 - $605,867
20,379 New
20,379 $565,000
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $15,884 - $18,567
495 New
495 $16,000
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $352,382 - $458,750
8,946 New
8,946 $364,000
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $182,698 - $223,028
4,175 Added 206.27%
6,199 $271,000
Q2 2022

Aug 17, 2022

SELL
$46.53 - $55.17 $14 Million - $16.6 Million
-300,500 Reduced 99.33%
2,024 $106,000
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $13.4 Million - $15.9 Million
288,889 Added 2118.73%
302,524 $2.4 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $16.5 Million - $20.5 Million
-361,145 Reduced 96.36%
13,635 $706,000
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $14.6 Million - $21.6 Million
353,285 Added 1643.57%
374,780 $22.1 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $451,453 - $579,930
11,502 Added 115.1%
21,495 $923,000
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $106,257 - $120,372
-2,959 Reduced 22.85%
9,993 $391,000
Q1 2021

May 17, 2021

SELL
$33.49 - $37.77 $1.88 Million - $2.12 Million
-56,123 Reduced 81.25%
12,952 $469,000
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $1.37 Million - $1.75 Million
-41,023 Reduced 37.26%
69,075 $2.54 Million
Q3 2020

Nov 16, 2020

SELL
$31.75 - $37.25 $977,106 - $1.15 Million
-30,775 Reduced 21.85%
110,098 $4.04 Million
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $4.73 Million - $5.74 Million
-157,107 Reduced 52.72%
140,873 $4.61 Million
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $6.81 Million - $9.73 Million
251,925 Added 547.01%
297,980 $9.73 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $1.09 Million - $1.24 Million
33,126 Added 256.21%
46,055 $1.8 Million
Q3 2019

Nov 13, 2019

BUY
$32.49 - $42.13 $110,108 - $142,778
3,389 Added 35.52%
12,929 $464,000
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $328,843 - $398,867
9,540 New
9,540 $420,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $144B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.